We applaud the study of Baxter et al. (1), in which the authors examined trends in treatments for ductal carcinoma in situ (DCIS) and the association between treatment and diagnosis year, race, tumor size, comedo histology, and geographic area by use of data from the Surveillance, Epidemiology, and End Results (SEER) 1 registries. They argue that some of the change in treatment patterns over time is related to modifiable practice patterns, particularly, because nonclinical factors are associated with treatment choice.
apy included women who had two or more Medicare claims for radiotherapy or a SEER designation of having radiation, because these sources are considered complementary in terms of their information (3).
In addition to geographic region (represented by SEER registry), year of diagnosis, age, and race being associated with treatment choice, we also found that socioeconomic and health system variables, including marital status, living in a rural area, and educational attainment, helped explain treatment variation. These variables are not related to modifiable practice patterns identified at the region level, calling into question the efficacy of national treatment guidelines. On the other hand, we found a small but statistically significant relationship between the density of radiation oncologists and treatment patterns, indicating that a high population ate of radiation oncologists may also influence care. If a referring surgeon knows that multiple radiation oncologists are available in the area, the surgeon may be more likely to refer patients for these services. Alternatively, perhaps, more radiation oncologists are in the area because the practice of local surgeons is to refer patients for radiation treatment.
Our work broadens the focus of Baxter et al. by examining geographic variation and trends in treatment by using novel methods to assess the diffusion of scientific information, such as clinical trial evidence showing that BCS alone is associated with worse long-term outcomes in terms of recurrence rates (4). We demonstrate that treatment trends in the 1990s are in an increasingly variable stage, meaning that there appears to be growing uncertainty, rather than consensus, over which treatment to choose. This observation may be a compelling reason to consider national treatment guidelines. 
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1 Editor's note: SEER is a set of geographically defined, population-based, central cancer registries in the United States, operated by local nonprofit organizations under contract to the National Cancer Institute (NCI). Registry data are submitted electronically without personal identifiers to the NCI on a biannual basis, and the NCI makes the data available to the public for scientific research.
